Crossmark

Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease

Crossref DOI link: https://doi.org/10.1016/j.stemcr.2020.04.011

Published Print: 2020-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Yamaguchi, Akihiro

Ishikawa, Kei-ichi https://orcid.org/0000-0003-2305-301X
Inoshita, Tsuyoshi

Shiba-Fukushima, Kahori

Saiki, Shinji

Hatano, Taku

Mori, Akio

Oji, Yutaka

Okuzumi, Ayami

Li, Yuanzhe

Funayama, Manabu

Imai, Yuzuru

Hattori, Nobutaka

Akamatsu, Wado
Funding

Funding for this research was provided by:

Ministry of Education, Culture, Sports, Science and Technology (S1411007)

Japan Agency for Medical Research and Development (17H04049)

Japan Agency for Medical Research and Development (18H02744)

Japan Agency for Medical Research and Development (18H04043)

Japan Agency for Medical Research and Development (18K15463)

Japan Society for the Promotion of Science
License Information

Text and Data Mining valid from 2020-06-01

Text and Data Mining valid from 2020-06-01

Version of Record valid from 2020-04-30
More Information

This article is maintained by: Elsevier

Article Title: Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease

Journal Title: Stem Cell Reports

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.stemcr.2020.04.011

Content Type: article

Copyright: © 2020 The Authors.